Mupirocin and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mupirocin (mupirocin) and Meropenem (meropenem). Common drug interactions include odynophagia among females and pulmonary embolism among males.

The phase IV clinical study analyzes what interactions people have when they take Mupirocin and Meropenem. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.



On Jul, 14, 2026

63 people who take Mupirocin and Meropenem together, and have interactions are studied.

Mupirocin and Meropenem drug interactions.

What are the common drug interactions of Mupirocin and Meropenem, by gender? *:

female:

  1. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Throat irritation
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Weight decreased
  6. Cough
  7. Folate deficiency (lack of folic acid)
  8. Lethargy (tiredness)
  9. Rash pruritic (redness with itching)
  10. Neuropathy peripheral (surface nerve damage)

male:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Septic shock (shock due to blood infection)
  3. C-reactive protein increased
  4. Confusional state
  5. Diarrhoea
  6. Dyspnoea (difficult or laboured respiration)
  7. General physical health deterioration (weak health status)
  8. Haematemesis (vomiting of blood)
  9. Haemophilus infection (bacterial infection by haemophilus influenzae)
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

What are the common drug interactions of Mupirocin and Meropenem, by age (0-1 to 60+)? *:

0-1:

  1. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  2. Haematocrit increased
  3. Pulseless electrical activity
  4. Septic shock (shock due to blood infection)
  5. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)

2-9:

  1. Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
  2. Diarrhoea
  3. Diarrhoea haemorrhagic (bloody diarrhoea)
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Pleural effusion (water on the lungs)
  7. Pyrexia (fever)
  8. Septic shock (shock due to blood infection)
  9. Tooth abscess (pus formation in tooth)

10-19:

n/a

20-29:

  1. Abdominal infection
  2. Abdominal pain upper
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  5. Asthenia (weakness)
  6. Back pain
  7. Blood cholesterol increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bronchopleural fistula
  10. Cardiac failure congestive

30-39:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Confusional state
  3. Diarrhoea
  4. General physical health deterioration (weak health status)
  5. Haematemesis (vomiting of blood)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Hallucination (an experience involving the perception of something not present)
  8. Hyperbilirubinaemia (excess of bilirubin in the blood)
  9. Hypotension (abnormally low blood pressure)
  10. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)

40-49:

  1. Enterocutaneous fistula
  2. Abscess limb (limb infection)
  3. Cellulitis (infection under the skin)
  4. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  5. Nerve injury
  6. Pain
  7. Perirectal abscess
  8. Rectal abscess (pus in rectum)
  9. Scar
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Hepatic failure (liver failure)
  2. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  3. Nerve injury
  4. Pain
  5. Panic attack
  6. Penile abscess
  7. Perirectal abscess
  8. Platelet count decreased
  9. Pneumonia
  10. Scrotal abscess (pus in scrotum)

60+:

  1. Fatigue (feeling of tiredness)
  2. Pyrexia (fever)
  3. Disease progression
  4. Dyspepsia (indigestion)
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Folate deficiency (lack of folic acid)
  7. Hyperchlorhydria (gastric acid levels are higher in stomach)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Lethargy (tiredness)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Diarrhea: 28 people, 44.44%
  2. Breast Cancer Metastatic: 27 people, 42.86%
  3. Lower Respiratory Tract Infection: 27 people, 42.86%
  4. Blood Folate Decreased: 26 people, 41.27%
  5. Constipation: 9 people, 14.29%
  6. Pain: 9 people, 14.29%
  7. Nausea (feeling of having an urge to vomit): 7 people, 11.11%
  8. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 9.52%
  9. High Blood Pressure: 6 people, 9.52%
  10. Hypotension (abnormally low blood pressure): 6 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Mupirocin and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mupirocin and Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mupirocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meropenem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mupirocin and meropenem (the active ingredients of Mupirocin and Meropenem, respectively), and Mupirocin and Meropenem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: